Morepen Laboratories Limited
_logo.png){kind=logo} | |
| Company type | Public |
|---|---|
| BSE: 500288, NSE: MOREPENLAB | |
| Industry | Pharmaceuticals, Medical Devices |
| Founded | 1984 |
| Founder | Sushil Suri |
Area served | Worldwide |
Key people | Sushil Suri (Chairman and Managing Director) |
| Products | Active pharmaceutical ingredients, OTC drugs, diagnostic devices |
| Brands | Dr. Morepen, Burnol, Lemolate |
| Revenue | ₹1,512 crore (FY 2022–23)[1] |
| Website | www |
Morepen Laboratories Limited is an Indian multinational pharmaceutical and healthcare company headquartered in Gurugram, Haryana. It was founded in 1984 and is involved in the manufacture of active pharmaceutical ingredients (APIs), over-the-counter (OTC) products, diagnostic devices, and branded formulations.[2] The company owns and operates a large manufacturing campus in Baddi, Himachal Pradesh.[3] It is known for popular healthcare brands such as Burnol, Lemolate, and diagnostic devices like glucometers and blood pressure monitors.[4]
References
[edit]- ^ "Morepen Laboratories Annual Report 2022–23" (PDF). Retrieved 8 August 2025.
- ^ "Morepen Laboratories Ltd. Company Profile". Moneycontrol. Retrieved 8 August 2025.
- ^ "Morepen Laboratories ramps up production of key drugs". Business Standard. 1 June 2021. Retrieved 8 August 2025.
- ^ "Morepen Labs posts 37% rise in net profit in Q4". The Economic Times. 10 June 2021. Retrieved 8 August 2025.